{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "22633969", "DateCompleted": {"Year": "2012", "Month": "12", "Day": "07"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1016/j.actbio.2012.05.017"], "ArticleDate": [{"Year": "2012", "Month": "05", "Day": "22"}], "Journal": {"ISSN": "1878-7568", "JournalIssue": {"Volume": "8", "Issue": "9", "PubDate": {"Year": "2012", "Month": "Sep"}}, "Title": "Acta biomaterialia", "ISOAbbreviation": "Acta Biomater"}, "ArticleTitle": "Healing of complement activating Ti implants compared with non-activating Ti in rat tibia.", "Pagination": {"StartPage": "3532", "EndPage": "3540", "MedlinePgn": "3532-40"}, "Abstract": {"AbstractText": ["Recent studies have revealed that ozone ultraviolet (UVO) illumination of titanium (Ti) implants improves bone-implant anchorage by altering the physico-chemical and immune activating properties of the titanium dioxide (TiO(2)) layer. In the present rat tibia model, the authors compared the early events of inflammation and bone formation around UVO-treated Ti and complement activating immunoglobin g (IgG)-coated Ti. Machined Ti and machined Ti coated with a physical vapour-deposited Ti layer were used as references. Screw-shaped test and reference implants were implanted into rat tibia and harvested after 1, 7 and 28 days. Messenger RNA expression of implant adhered cells and peri-implant tissue ~250 \u03bcm from the surface were subsequently analysed with regard to IL-1\u03b2, TNF-\u03b1, osteocalcin, cathepsin K, BMP-2 and PDGF. Separate implants were retrieved after 7 and 28 days for removal torque measurements, and histological staining and histomorphometric analysis of bone area and bone-to-implant contact. While enhanced expression of inflammatory markers, TNF-\u03b1 and IL-1\u03b2, was observed on IgG-coated surfaces throughout the observation time, UVO-treated surfaces indicated a significantly lower early inflammatory response. In the early phases (1 and 7 days), the UVO-treated surfaces displayed a significantly higher expression of osteoblast markers BMP-2 and osteocalcin. In summary, complement activating Ti implants elicited a stronger inflammatory response than UVO-treated Ti, with low complement activation during the first week of healing. In spite of this, the UVO-treated Ti induced only marginally more bone growth outside the implants."], "CopyrightInformation": "Copyright \u00a9 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomaterials, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. neco@biomaterials.gu.se"}], "Identifier": [], "LastName": "Harmankaya", "ForeName": "N", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Igawa", "ForeName": "K", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Stenlund", "ForeName": "P", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Palmquist", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tengvall", "ForeName": "P", "Initials": "P"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Acta Biomater", "NlmUniqueID": "101233144", "ISSNLinking": "1742-7061"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "D1JT611TNE", "NameOfSubstance": "Titanium"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Complement Activation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Microscopy, Electron, Scanning"}, {"QualifierName": [], "DescriptorName": "Polymerase Chain Reaction"}, {"QualifierName": [], "DescriptorName": "Prostheses and Implants"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Tibia"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Titanium"}, {"QualifierName": [], "DescriptorName": "Ultraviolet Rays"}, {"QualifierName": [], "DescriptorName": "Wound Healing"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2012", "Month": "2", "Day": "27"}, {"Year": "2012", "Month": "5", "Day": "6"}, {"Year": "2012", "Month": "5", "Day": "15"}, {"Year": "2012", "Month": "5", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "5", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["22633969", "10.1016/j.actbio.2012.05.017", "S1742-7061(12)00221-8"]}}], "PubmedBookArticle": []}